Compile Data Set for Download or QSAR
Report error Found 174 Enz. Inhib. hit(s) with all data for entry = 9922
TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499334BDBM499334(4-((3-(6- (cyclopropylmethoxy)pyridin-3- yl)phenox...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499388BDBM499388(4-((3-(5- (cyclopropylmethyl)isoxazol-3- yl)phenox...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499334BDBM499334(4-((3-(6- (cyclopropylmethoxy)pyridin-3- yl)phenox...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499324BDBM499324(4-((3-(6- (cyclopropylmethoxy)pyridin-3- yl)phenox...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499313BDBM499313(4-((3-(6- (cydopropylmethoxy)pyridin-3- yl)phenoxy...)
Affinity DataIC50: 80nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499402BDBM499402(4-((3-(5-chloro-6- (cyclopropylmethoxy)pyridin-3- ...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499401BDBM499401(tert-butyl 3-(((5-(3-((2-fluoro-4- ((methylsulfony...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499400BDBM499400(4-((3-(5-chloro-6- (cyclopropylmethoxy)pyridin-3- ...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499399BDBM499399(4-((3-(6-(cyclopropylmethoxy)- 4-methylpyridin-3-y...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499398BDBM499398(4-((3-(6-(cyclopropylmethoxy)- 4-methylpyridin-3- ...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499397BDBM499397(4-((3-(6-(cyclopropylmethoxy)- 2-methylpyridin-3-y...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499396BDBM499396(4-((3-(6-(cyclopropylmethoxy)- 5-methylpyridin-3-y...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499395BDBM499395(4-((3-(6-(cyclopropylmethoxy)- 5-methylpyridin-3- ...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499394BDBM499394(4-((3-(6-(cyclobutylmethoxy)-2- methylpyridin-3-yl...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499393BDBM499393(4-((3-cyano-5-(6- (cyclopropylmethoxy)pyridin-3- y...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499392BDBM499392(4-((3-fluoro-5-(6- ((tetrahydrofuran-3- yl)methoxy...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499391BDBM499391(3-fluoro-N-(methylsulfonyl)-4- ((3-(6-((tetrahydro...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499390BDBM499390(4-((3-(6-(cyclopropylmethoxy)- 2-methylpyridin-3-f...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499389BDBM499389(4-((3-(6-(cyclopropylmethoxy)- 2-methylpyridin-3- ...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499388BDBM499388(4-((3-(5- (cyclopropylmethyl)isoxazol-3- yl)phenox...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499387BDBM499387(4-((3-(1-(cyclopropylmethyl)- 1H-pyrazol-3- yl)phe...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499418BDBM499418(4-((3-(6- (cyclopropylmethoxy)pyridin-2- yl)phenox...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499417BDBM499417(6-((3-(6- (cyclobutylmethoxy)pyridin-3- yl)phenoxy...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499416BDBM499416(4-((3-(5- (cyclopropylmethoxy)pyridin-3- yl)-5-flu...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499415BDBM499415(4-((3-(5- (cyclopropylmethoxy)pyridin-3- yl)phenox...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499414BDBM499414(4-((3-(6- (cyclopropylmethoxy)pyridin-3- yl)-5-(py...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499413BDBM499413(4-((3-(6- (cyclopropylmethoxy) pyridin-3-yl)- 5-(1...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499412BDBM499412(4-((3-(6- (cyclopropylmethoxy) pyridin-3-yl)- 5-(p...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499411BDBM499411(4-(((5-(6- (cyclopropylmethoxy) pyridin-3-yl)- [1,...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499410BDBM499410(4-((3-(6-(cyclobutylmethoxy)-2- (hydroxymethyl)pyr...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499409BDBM499409(4-((3-(6-(cyclobutylmethoxy)-2- (hydroxymethyl)pyr...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499408BDBM499408(4-((3-(6-(cyclobutylmethoxy)-5- (hydroxymethyl)pyr...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499407BDBM499407(4-((3-(6-(cyclobutylmethoxy)-5- (hydroxymethyl)pyr...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499406BDBM499406(4-((3-(6-(cyclobutylmethoxy)-5- (hydroxymethyl)pyr...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499405BDBM499405(4-((3-(6-(cyclobutylmethoxy)-5- (hydroxymethyl)pyr...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499404BDBM499404(4-((3-(6-(cyclopropylmethoxy)-2- methylpyridin-3-y...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499403BDBM499403(4-((3-(5-chloro-6- (cyclopropylmethoxy)pyridin-3- ...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499434BDBM499434(4-((3-(4- (cyclopropylmethoxy)pyridin-2- yl)phenox...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499433BDBM499433(4-((3-(4- (cyclopropylmethoxy)pyridin-2- yl)phenox...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499432BDBM499432(4-((3-(4- (cyclopropylmethoxy)pyridin-2- yl)-5-flu...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499431BDBM499431(4-((3-(4-(cyclopropylmethoxy)-3- methylpyridin-2-y...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499430BDBM499430(4-((3-(4-(cyclopropylmethoxy)-3- methylpyridin-2- ...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499429BDBM499429(4-((3-(5- (cyclopropylmethoxy)pyridin-2- yl)-5-flu...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499428BDBM499428(4-((3-(5- (cyclopropylmethoxy)pyridin-2- yl)phenox...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499427BDBM499427(4-((3-(5-(cyclobutylmethoxy)-3- methylpyridin-2- y...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499426BDBM499426(4-((3-(5-(cyclopropylmethoxy)-3- methylpyridin-2- ...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499425BDBM499425(4-((3-(5-(cyclobutylmethoxy)-3- methylpyridin-2-yl...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499424BDBM499424(4-((3-(5-(cyclopropylmethoxy)-3- methylpyridin-2- ...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499423BDBM499423(4-((3-(5-(cyclopropylmethoxy)- 3-fluoropyridin-2-y...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 499422BDBM499422(4-((3-(5-(cyclopropylmethoxy)- 3-fluoropyridin-2-y...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent

Displayed 1 to 50 (of 174 total ) | Next | Last >>
Jump to: